Obesity, Bariatric Surgery, the Gut Microbiome, and Immunotherapy Response in Breast Cancer

Friday, June 27, 2025

8:00am - 8:30am East Coast USA Time

Location: Salons F-G

Speaker(s)

Liza Makowski, PhD, MS

Professor
University of Tennessee
Memphis, Tennessee, United States

Disclosure(s):

Liza Makowski, PhD, MS: No financial relationships to disclose

Understand how obesity impacts breast cancer risk, therapeutic outcomes, and survival.
Review clincial studies on obesity and weight loss through bariatric (metabolic) surgery or medical weight loss such as GLP-1 agonists.
Detail results from pre-clinical studies of obesity and weight loss, the gut microbiome, and response to immunotherapy in breast cancer.